BioCryst Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BCRX Nasdaq 2830 www.biocryst.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Mar 6th, 2025 12:00 pm
Is BioCryst Pharmaceuticals, Inc. (BCRX) the Best Small-Cap Stock to Buy Now? - Mar 1st, 2025 2:13 pm
BioCryst (BCRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Feb 27th, 2025 3:30 pm
Here's Why BioCryst (BCRX) Could be Great Choice for a Bottom Fisher - Feb 26th, 2025 2:55 pm
Wall Street Analysts Predict an 84.18% Upside in BioCryst (BCRX): Here's What You Should Know - Feb 26th, 2025 2:55 pm
Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its Yearly Results - Feb 26th, 2025 10:54 am
Company News for Feb 25, 2025 - Feb 25th, 2025 2:21 pm
BioCryst Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations - Feb 25th, 2025 10:41 am
Q4 2024 BioCryst Pharmaceuticals Inc Earnings Call - Feb 25th, 2025 7:28 am
BioCryst Pharmaceuticals Inc (BCRX) Q4 2024 Earnings Call Highlights: Strong ORLADEYO Revenue ... - Feb 25th, 2025 7:01 am
Why BioCryst Pharmaceuticals Stock Tumbled by 10% Today - Feb 24th, 2025 11:15 pm
BioCryst Pharmaceuticals (BCRX) Q4 2024 Earnings Call Transcript - Feb 24th, 2025 9:30 pm
BioCryst Pharmaceuticals (BCRX) Reports Q4 Loss, Tops Revenue Estimates - Feb 24th, 2025 1:10 pm
BioCryst: Q4 Earnings Snapshot - Feb 24th, 2025 12:17 pm
BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones - Feb 24th, 2025 12:00 pm
BioCryst Announces Positive Results from APeX-P Trial for ORLADEYO® (berotralstat) in Pediatric Patients with Hereditary Angioedema Aged 2 to <12 Years - Feb 24th, 2025 11:00 am
BioCryst to Present at Upcoming Investor Conferences - Feb 19th, 2025 12:00 pm
BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Feb 17th, 2025 3:00 pm
BioCryst Launches ORLADEYO® (berotralstat) in Portugal - Feb 12th, 2025 12:00 pm
Exploring Three High Growth Tech Stocks In The United States - Feb 10th, 2025 2:02 pm